An experimental study on the influence of metformin on monosodium glutamate‑treated depressed Wistar albino male rats
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20261108Keywords:
Monosodium glutamate, Metformin, Imipramine, Interleukin-6, Brain-derived neurotrophic factorAbstract
Background: The current experiment aimed to determine the antidepressant-like properties of metformin in a monosodium glutamate- induced depression model in Wistar albino male rats.
Methods: The subjects were subjected to depression induced using oral intake of 500 mg/kg of MSG over a period of 21 days. The experimental period was between day 9 and day 21, during which metformin and an antidepressant drug, the standard dose of imipramine, were administered. The sacrifice of animals was conducted on day 23, and biochemical analyses were performed on the supernatants of hippocampal and amygdaloid tissues. Statistical analysis was done with a significance of p<0.05.
Results: MSG exposure led to a high level of interleukin-6 (IL-6) and a low level of brain-derived neurotrophic factor (BDNF). Metformin and imipramine treatment led to a significant decrease in IL-6 levels and a significant increase in BDNF concentrations compared with the MSG-treated group (p<0.001). The results of metformin were similar to the impact of a standard drug, imipramine.
Conclusions: The observed study results indicate that metformin has antidepressant-like properties in MSG-induced depressed rats, which could be due to the inhibition of neuroinflammation and the promotion of neurotrophic support.
References
Kuehner C. Why is depression more common among women than men?. Lancet Psychiatry. 2017;4(2):146-58.
Thombs BD, Bass EB, Ford DE, Stewart DE, Ziegelstein RC, Cook RJ, et al. Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med. 2006;21(1):30-8.
Hawton K, Casañas ICC, Haw C, Saunders K. Risk factors for suicide in depression. Lancet. 2013;381:193-204.
Husarova V, Ostatnikova D. Monosodium glutamate: Toxic effects and implications for humans. Physiol Res. 2013;62(4):455-63.
Diniz TC, Silva JC, de Lima-Saraiva SRG, Gomes R, de Oliveira AA. Monosodium glutamate induces depressive-like behavior and oxidative stress in the hippocampus of rats. Neurotoxicology. 2018;67:27-34.
Wang Y, Liu C, Zhu S. Metformin exerts antidepressant effects by inhibiting neuroinflammation. Brain Behav Immun. 2023;109:152-60.
Zheng W, Yang X, Hu Y. Metformin increases hippocampal BDNF and neurogenesis. Neuroscience. 2024;529:56-65.
Réus GZ, Abelaira HM, Agostinho FR, Comim CM, Ritter C, dos Santos DB, et al. Metformin treatment reverses depressive-like behavior and alters hippocampal neuroplasticity in rats. Behav Brain Res. 2019;364:155-62.
Seo JS, Park MH, Kim JH. Activation of AMPK improves synaptic function under chronic stress. Neuropharmacology. 2022;214:109175.
Ghosh MN. Fundamentals of Experimental Pharmacology. Hilton and Company. 2011;165-72.
Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H, et al. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine. 1997;9:853-8.
Garcia LS, Comim CM, Valvassori SS, Réus GZ, Barbosa LM, Andreazza AC, et al. Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:140-4.
Fang W, Zhang J, Hong L, Huang W, Dai X, Ye Q, et al. Metformin ameliorates stress-induced depression-like behaviors via enhancing the expression of BDNF by activating AMPK/CREB-mediated histone acetylation. J Affect Disord. 2020;260:302-13.
Patil SP, Jain PD, Ghumatkar PJ. Neuroprotective and antidepressant-like effects of metformin in rat models of neuroinflammation. Inflammopharmacology. 2020;28(4):1031-42.
Lu Y, Ho CS, McIntyre RS. Metformin attenuates depressive-like behavior by inhibiting NLRP3 inflammasome activation in rats exposed to chronic stress. J Neuroinflamm. 2021;18:194.
Zhang Y, Liu L, Peng YL, Li J, Chen H, Wang X, et al. Antidepressant-like effects of metformin in a chronic mild stress model in rats: involvement of neuroinflammatory pathways. Neurosci Lett. 2020;736:135263.
Kim J, Kwak HJ, Cha JY, Jeong YS, Rhee SD, Kim KR, et al. Metformin suppresses lipopolysaccharide-induced inflammatory response in murine macrophages via activating transcription factor-3 (ATF-3) induction. J Biol Chem. 2014;289(33):23246-55.
Downloads
Published
How to Cite
Issue
Section
